Point mutations in RUNX1, TP53 and NRAS were associated with severe thrombocytopenia and an increased proportion of bone marrow blasts, whereas point mutations in TP53, EZH2, ETV6, RUNX1 and ASXL1 were associated with shorter overall survival [8]. The gene discussed is TP53; the disease is Thrombocytopenia.